Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
230
-
Total 13F shares, excl. options
-
112M
-
Shares change
-
+371K
-
Total reported value, excl. options
-
$1.04B
-
Value change
-
+$6.56M
-
Put/Call ratio
-
0.24
-
Number of buys
-
112
-
Number of sells
-
-96
-
Price
-
$9.24
Significant Holders of NEOGENOMICS INC - Common Stock (NEO) as of Q4 2022
268 filings reported holding NEO - NEOGENOMICS INC - Common Stock as of Q4 2022.
NEOGENOMICS INC - Common Stock (NEO) has 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 112M shares
of 129M outstanding shares and own 87% of the company stock.
Largest 10 shareholders include BlackRock Inc. (21.9M shares), VANGUARD GROUP INC (13.7M shares), BROWN ADVISORY INC (6.4M shares), JANUS HENDERSON GROUP PLC (6.13M shares), STATE STREET CORP (4.65M shares), T. Rowe Price Investment Management, Inc. (2.92M shares), Greenhouse Funds LLLP (2.8M shares), GOLDMAN SACHS GROUP INC (2.78M shares), First Light Asset Management, LLC (2.68M shares), and MILLENNIUM MANAGEMENT LLC (2.66M shares).
This table shows the top 230 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.